Chemokine (C-X-C motif) ligand 16 (CXCL16)/chemokine receptor 6 (CXCR6) signaling elicits anti-inflammatory effects in glioma by driving microglia polarization [92]. Here, CXCL16 is linked to central nervous system cancer.